drugset
drugset / Trial / NCT00002844

Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00002844 ↗

Phase 2 Completed 49 enrolled M.D. Anderson Cancer Center National Cancer Institute (NCI) · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients with chronic lymphocytic leukemia.

Timeline

Start
1991-03-05
Primary completion
2002-06-05
Completion
2002-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified — Intravenous

Indications

leukemia